Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Essential Thrombocythemia

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelets Counts <50,000/µL) (PAC203)

  • Details

ClinicalTrials.gov ID: NCT03165734
Diagnosis Type: NA
USOR Number: 19171

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Myelofibrosis

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelets Counts <50,000/µL) (PAC203)

  • Details

ClinicalTrials.gov ID: NCT03165734
Diagnosis Type: NA
USOR Number: 19171

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Myelomas

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

207495: A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide plus Low-dose Dexamethasone (pom/dex) in Participants with Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM3)

  • Details

ClinicalTrials.gov ID: NCT04162210
Diagnosis Type: NA
USOR Number: 18229

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

ENGOT-ov50 / INNOVATE-3: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 200kHz) Concomitant with Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer

  • Details

ClinicalTrials.gov ID: NCT03940196
Diagnosis Type: NA
USOR Number: 18269

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Vaginal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Brain Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Liver Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Fallopian Tube Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Vulvar Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Testicular Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Anal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Cervical Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Malignant Adenoma

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Thyroid Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Pages